CL-H1T

· Charleston Laboratories, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CL-H1T, covering 2019-11-01 to 2019-11-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain [Phase 2]